Metin Yusuf Gelmez
Research Subjects
Metin Yusuf Gelmez has a total of 185 co-authors. Here are the top co-authors by number of shared publications:
- Gunnur Deniz
Istanbul University, Aziz Sancar Institute of Experimental Medicine
10 shared publications - Suzan Çinar
Department of Immunology, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Türkiye
5 shared publications - Ipek Yonal-Hindilerden
Istanbul University Faculty of Medicine, Department of Adult Hematopoietic Stem Cell Transplantation Unit, Istanbul, Turkey
4 shared publications - Fatma Betul Oktelik
Department of Immunology, Aziz Sancar Institute of Experimental Medicine (Aziz Sancar DETAE), Istanbul University, Istanbul, Turkey
3 shared publications - Melih Aktan
Istanbul University, Istanbul Faculty of Medicine, Department of Internal Medicine, Division of Hematology, Istanbul, Turkey
3 shared publications - Murat Ozbalak
Istanbul Medical Faculty, Department of Hematology Istanbul University Istanbul Turkey
3 shared publications
Latest Publications
- 22 October 2025
- Published by Kocaeli University in Acta Medica Nicomedia
- Vol. 8 (3) , 308-313
Kronik Lenfositik Lösemi Hastalarında CXCR5+CD8+ Foliküler Sitotoksik T hücreleri, CD8+ T hücreleri ve NK Hücrelerinde Perforin ve Granzim Seviyeleri
Amaç: Kronik lenfositik lösemi (KLL), bir T hücre belirteci olan CD5 proteinini aberan olarak ifade eden CD19+ malign B hücrelerin lenf nodu, kan ve kemik iliğinde biriktiği lösemi tipidir. KLL hastalarında CD8+ T, NK ve foliküler sitotoksik T (TFC) hücre oranları ve fonksiyonlarını inceleyen farklı çalışmalar bulunmakla birlikte, bu hücrelerin perforin ve granzim içeriklerini karşılaştıran bir çalışma bulunmamaktadır. Bu çalışmada KLL hastalarında CD8+ T, NK ve TFC hücrelerin perforin ve granzim seviyeleri incelenmiştir. Yöntem: Tedavi almayan KLL tanılı 14 hasta ve 9 sağlıklı birey çalışmaya dahil edilmiştir. CD8+ T, NK ve TFC hücre oranları ve bu hücrelerde perforin ve granzim seviyeleri akan hücre ölçer sistemi ile saptanmıştır. Bulgular: KLL hastalarında NK hücrelerinin azaldığı, buna karşılık CD8+ T ve TFC hücrelerinin arttığı tespit edilmiştir. Sağlıklı bireyler ile karşılaştırıldığında, KLL hastalarının NK hücrelerinde granzim B seviyesinin düşük, TFC hücrelerinde ise yüksek olduğu gözlenirken, perforin seviyesinin her üç hücre grubunda da arttığı belirlenmiştir. KLL hastalarının CD8+ T, NK ve TFC hücrelerindeki perforin ve granzim içerikleri kendi aralarında değerlendirildiğinde, NK ve TFC hücrelerinde CD8+ T hücrelerine göre daha yüksek perforin seviyelerine sahip olduğu gözlenmiştir. Sonuç: KLL hastalarında NK hücrelerinin sayıca azalması ve düşük perforin içerikleri, NK hücrelerinin KLL patogenezindeki rolünün diğer sitotoksik hücrelere göre daha sınırlı olabileceğini düşündürmektedir. Bulgularımız TFC hücrelerin KLL patogenezinde malign B hücrelerine karşı daha etkili olabileceğini ve immünoterapilerde hedeflenebilecek potansiyel bir hücre grubu olarak değerlendirilebileceğini göstermektedir.
- 22 October 2025
- Published by Kocaeli University in Acta Medica Nicomedia
- Vol. 8 (3) , 308-313
Kronik Lenfositik Lösemi Hastalarında CXCR5+CD8+ Foliküler Sitotoksik T hücreleri, CD8+ T hücreleri ve NK Hücrelerinde Perforin ve Granzim Seviyeleri
Amaç: Kronik lenfositik lösemi (KLL), bir T hücre belirteci olan CD5 proteinini aberan olarak ifade eden CD19+ malign B hücrelerin lenf nodu, kan ve kemik iliğinde biriktiği lösemi tipidir. KLL hastalarında CD8+ T, NK ve foliküler sitotoksik T (TFC) hücre oranları ve fonksiyonlarını inceleyen farklı çalışmalar bulunmakla birlikte, bu hücrelerin perforin ve granzim içeriklerini karşılaştıran bir çalışma bulunmamaktadır. Bu çalışmada KLL hastalarında CD8+ T, NK ve TFC hücrelerin perforin ve granzim seviyeleri incelenmiştir. Yöntem: Tedavi almayan KLL tanılı 14 hasta ve 9 sağlıklı birey çalışmaya dahil edilmiştir. CD8+ T, NK ve TFC hücre oranları ve bu hücrelerde perforin ve granzim seviyeleri akan hücre ölçer sistemi ile saptanmıştır. Bulgular: KLL hastalarında NK hücrelerinin azaldığı, buna karşılık CD8+ T ve TFC hücrelerinin arttığı tespit edilmiştir. Sağlıklı bireyler ile karşılaştırıldığında, KLL hastalarının NK hücrelerinde granzim B seviyesinin düşük, TFC hücrelerinde ise yüksek olduğu gözlenirken, perforin seviyesinin her üç hücre grubunda da arttığı belirlenmiştir. KLL hastalarının CD8+ T, NK ve TFC hücrelerindeki perforin ve granzim içerikleri kendi aralarında değerlendirildiğinde, NK ve TFC hücrelerinde CD8+ T hücrelerine göre daha yüksek perforin seviyelerine sahip olduğu gözlenmiştir. Sonuç: KLL hastalarında NK hücrelerinin sayıca azalması ve düşük perforin içerikleri, NK hücrelerinin KLL patogenezindeki rolünün diğer sitotoksik hücrelere göre daha sınırlı olabileceğini düşündürmektedir. Bulgularımız TFC hücrelerin KLL patogenezinde malign B hücrelerine karşı daha etkili olabileceğini ve immünoterapilerde hedeflenebilecek potansiyel bir hücre grubu olarak değerlendirilebileceğini göstermektedir.
- 6 August 2025
- Published by Springer Nature in Immunologic Research
- Vol. 73 (1) , 1-11
The role of CD40L-expressing CXCR5+CD8+ follicular cytotoxic T cells in chronic lymphocytic leukemia
A newly identified cell subset within CD8+ T cells expressing CXCR5 of follicular cytotoxic T cells (TFC) lyse the infected or tumor cells. Recent studies have suggested that some TFC cell subsets may be involved in the regulation of antibody responses. We aimed to determine the subset of TFC which differentiates in patients diagnosed with chronic lymphocytic leukemia (CLL) and their role in CLL immunopathogenesis. The peripheral blood mononuclear cells were isolated from 29 CLL patients and 19 healthy subjects. Intracellular IL-4, IL-17, IL-21, IFN-γ, perforin, and granzyme-B levels were investigated in TFC subsets. Increased levels of IL-4, IL-17, IL-21, IFN-γ and perforin, and decreased granzyme B expression levels were observed in CD40L+ TFC cells compared to the levels in CD40L− TFC cells in the analysis of healthy individuals. TFC and its subsets were analyzed in CLL patients and healthy individuals, TFC and CD40L+ TFC cells were increased in CLL patients and there was a positive correlation between TFC and CD5+CD19+ cells. Moreover, increased number of TFC cells were detected in CLL patients with more progressive disease. Higher expression level of IL-4, IL-17, IL-21, and IFN-γ was observed in CD40L+ TFC cells of patients compared to the levels in healthy controls. Our findings might indicate that CD40L+ TFC cells may have a B cell activating role rather than exhibiting a cytotoxic role. Considering the effects of CD40L+ TFC cells on B cells, determining subsets of TFC cells which differentiate and understanding the functions of these subsets is crucial to elucidate their roles in the pathogenesis of B cell malignancies.
- 6 August 2025
- Published by Springer Nature in Immunologic Research
- Vol. 73 (1) , 1-11
The role of CD40L-expressing CXCR5+CD8+ follicular cytotoxic T cells in chronic lymphocytic leukemia
A newly identified cell subset within CD8+ T cells expressing CXCR5 of follicular cytotoxic T cells (TFC) lyse the infected or tumor cells. Recent studies have suggested that some TFC cell subsets may be involved in the regulation of antibody responses. We aimed to determine the subset of TFC which differentiates in patients diagnosed with chronic lymphocytic leukemia (CLL) and their role in CLL immunopathogenesis. The peripheral blood mononuclear cells were isolated from 29 CLL patients and 19 healthy subjects. Intracellular IL-4, IL-17, IL-21, IFN-γ, perforin, and granzyme-B levels were investigated in TFC subsets. Increased levels of IL-4, IL-17, IL-21, IFN-γ and perforin, and decreased granzyme B expression levels were observed in CD40L+ TFC cells compared to the levels in CD40L− TFC cells in the analysis of healthy individuals. TFC and its subsets were analyzed in CLL patients and healthy individuals, TFC and CD40L+ TFC cells were increased in CLL patients and there was a positive correlation between TFC and CD5+CD19+ cells. Moreover, increased number of TFC cells were detected in CLL patients with more progressive disease. Higher expression level of IL-4, IL-17, IL-21, and IFN-γ was observed in CD40L+ TFC cells of patients compared to the levels in healthy controls. Our findings might indicate that CD40L+ TFC cells may have a B cell activating role rather than exhibiting a cytotoxic role. Considering the effects of CD40L+ TFC cells on B cells, determining subsets of TFC cells which differentiate and understanding the functions of these subsets is crucial to elucidate their roles in the pathogenesis of B cell malignancies.
- Open Access
- 30 June 2025
- Published by Kocaeli University in Acta Medica Nicomedia
- Vol. 8 (2) , 140-145
Kronik Lenfositik Lösemi Hastalarında Notch Ekspresyon Seviyeleri: Akan Hücre Ölçer ile Değerlendirilmesi
Amaç: CD5+CD19+ malign B hücrelerin kemik iliği ve kanda birikmesi ile karakterize kronik lenfositik lösemi (KLL), Amerika ve Avrupa’da yetişkinlerde en sık gözlenen lösemi tipidir. CD38, ZAP70 ekspresyonları, immünoglobülin ağır zincir değişken bölge (IgVH) mutasyonları hastalığın klinik seyri hakkında bilgi sağlasa da KLL patogenezi henüz net olarak tanımlanmamıştır. Transmembran proteini olan Notch reseptörleri hücre çoğalması, farklılaşması ve apoptozis süreçlerinde immün homeostazın sağlanmasında oldukça önemlidir. Güncel çalışmalar, Notch moleküllerinin kanser gelişiminde rolü olduğunu göstemektedir. Bu çalışmada KLL tanısı almış hastalarda Notch seviyeleri analiz edilerek KLL patogenezindeki rolleri incelenmiştir. Yöntem: KLL tanılı 15 hasta ve 9 sağlıklı bireyin periferik kanından izole edilen periferik kan mononükleer hücrelerde akan hücre ölçer ile Notch1, Notch2, Notch3 ve Notch4 seviyeleri değerlendirildi. Bulgular: KLL hastalarında lenfosit, CD19+ B ve CD3+ T hücrelerde Notch1 ifadesinin arttığı, buna karşın Notch4 ifadesinin ise azaldığı gözlendi. Hasta ve sağlıklı bireyler arasında Notch2 ve Notch3 ifadeleri arasında anlamlı fark gözlenmedi. Sonuç: Notch1hücreleri apoptoza karşı dirençli hale getirerek hücre sağ kalımı üzerine pozitif etkide bulunmaktadır. KLL hastalarında Notch1 gen ifadesinin yükseldiği ve kötü prognoz ile ilişkili olduğu bildirilmektedir. Bulgularımız akan hücre ölçer ile Notch ifadelerinin hastalarda hızlı bir şekilde değerlendirilebileceğini ve değişen Notch1 ve Notch4 ifadelerinin KLL patogenezinde incelenmesi gereken potansiyel belirteçler olarak öne çıkabileceğini göstermektedir.
- 30 June 2025
- Published by Kocaeli University in Acta Medica Nicomedia
- Vol. 8 (2) , 140-145
Open AccessKronik Lenfositik Lösemi Hastalarında Notch Ekspresyon Seviyeleri: Akan Hücre Ölçer ile Değerlendirilmesi
Amaç: CD5+CD19+ malign B hücrelerin kemik iliği ve kanda birikmesi ile karakterize kronik lenfositik lösemi (KLL), Amerika ve Avrupa’da yetişkinlerde en sık gözlenen lösemi tipidir. CD38, ZAP70 ekspresyonları, immünoglobülin ağır zincir değişken bölge (IgVH) mutasyonları hastalığın klinik seyri hakkında bilgi sağlasa da KLL patogenezi henüz net olarak tanımlanmamıştır. Transmembran proteini olan Notch reseptörleri hücre çoğalması, farklılaşması ve apoptozis süreçlerinde immün homeostazın sağlanmasında oldukça önemlidir. Güncel çalışmalar, Notch moleküllerinin kanser gelişiminde rolü olduğunu göstemektedir. Bu çalışmada KLL tanısı almış hastalarda Notch seviyeleri analiz edilerek KLL patogenezindeki rolleri incelenmiştir. Yöntem: KLL tanılı 15 hasta ve 9 sağlıklı bireyin periferik kanından izole edilen periferik kan mononükleer hücrelerde akan hücre ölçer ile Notch1, Notch2, Notch3 ve Notch4 seviyeleri değerlendirildi. Bulgular: KLL hastalarında lenfosit, CD19+ B ve CD3+ T hücrelerde Notch1 ifadesinin arttığı, buna karşın Notch4 ifadesinin ise azaldığı gözlendi. Hasta ve sağlıklı bireyler arasında Notch2 ve Notch3 ifadeleri arasında anlamlı fark gözlenmedi. Sonuç: Notch1hücreleri apoptoza karşı dirençli hale getirerek hücre sağ kalımı üzerine pozitif etkide bulunmaktadır. KLL hastalarında Notch1 gen ifadesinin yükseldiği ve kötü prognoz ile ilişkili olduğu bildirilmektedir. Bulgularımız akan hücre ölçer ile Notch ifadelerinin hastalarda hızlı bir şekilde değerlendirilebileceğini ve değişen Notch1 ve Notch4 ifadelerinin KLL patogenezinde incelenmesi gereken potansiyel belirteçler olarak öne çıkabileceğini göstermektedir.
- 7 March 2025
- Published by Academician Publishing
- p. 729-744
Bağışıklık Sistemi Organları, Hücre ve Mediyatörleri
İmmün sistem kendinden olmayan tüm çevresel, enfeksiyöz, patojen vb. ajanlara karşı organizmayı koruyan bir savunma mekanizmasıdır. İmmün sistem hücreleri patojenlerin protein, lipid, karbonhidrat, polisakkarid gibi yapılarını, vücudun mutasyona uğrayarak farklılaşan moleküllerini, tümör hücrelerini, enfeksiyöz olmayan bazı küçük kimyasalları ve hatta bazı durumlarda vücudun öz antijenlerini tanıyarak yanıt oluşturur. İmmün sistem, doğal ve edinsel immün sistemden oluşur. Bu iki sistem birbiriyle oldukça koordineli bir şekilde çalışır. Bu bölümde sırasıyla doğal ve edinsel immün sistem hücreleri ile immün sistem dokuları ele alınarak özellikleri, fonksiyonları ve rolleri hakkında bilgi verilecektir.
- 7 March 2025
- Published by Academician Publishing
- p. 729-744
Bağışıklık Sistemi Organları, Hücre ve Mediyatörleri
İmmün sistem kendinden olmayan tüm çevresel, enfeksiyöz, patojen vb. ajanlara karşı organizmayı koruyan bir savunma mekanizmasıdır. İmmün sistem hücreleri patojenlerin protein, lipid, karbonhidrat, polisakkarid gibi yapılarını, vücudun mutasyona uğrayarak farklılaşan moleküllerini, tümör hücrelerini, enfeksiyöz olmayan bazı küçük kimyasalları ve hatta bazı durumlarda vücudun öz antijenlerini tanıyarak yanıt oluşturur. İmmün sistem, doğal ve edinsel immün sistemden oluşur. Bu iki sistem birbiriyle oldukça koordineli bir şekilde çalışır. Bu bölümde sırasıyla doğal ve edinsel immün sistem hücreleri ile immün sistem dokuları ele alınarak özellikleri, fonksiyonları ve rolleri hakkında bilgi verilecektir.
- Open Access
- 7 March 2025
- Published by Academician Publishing
Tıp Fakülteleri için Mikrobiyoloji ve İmmunoloji Kitabı
- 7 March 2025
- Published by Academician Publishing
Open AccessTıp Fakülteleri için Mikrobiyoloji ve İmmunoloji Kitabı
- Open Access
- 17 February 2024
- Published by Springer Nature in Journal of Endocrinological Investigation
- Vol. 47 (8) , 2041-2052
Novel variants ensued genomic imprinting in familial central precocious puberty
Introduction: Central precocious puberty (CPP) is characterized by the early onset of puberty and is associated with the critical processes involved in the pubertal switch. The puberty-related gene pool in the human genome is considerably large though few have been described in CPP. Within those genes, the genomic imprinting features of the MKRN3 and DLK1 genes add additional complexity to the understanding of the pathologic pathways. This study aimed to investigate the molecular etiology in the CPP cohort. Methods: Eighteen familial CPP cases were investigated by Sanger sequencing for five CPP-related genes; DLK1, KISS1, KISS1R, MKRN3, and PROKR2. Segregation analysis was performed in all patients with pathogenic variants. Using an ELISA test, the functional pathogenicity of novel variants was also investigated in conjunction with serum delta-like 1 homolog (DLK1) concentrations. Results: In three probands, a known variant in the MKRN3 gene (c.982C>T/p.(Arg328Cys)) and two novel variants in the DLK1 gene (c.357C>G/p.(Tyr119Ter) and c.67+78C>T) were identified. All three were inherited from the paternal allele. The individuals carrying the DLK1 variants had low detectable DLK1 levels in their serum. Conclusions: The frequencies were 5.5% (1/18) for MKRN3 11% (2/18) for DLK1, and none for either KISS1, KISS1R, and PROKR2. Low serum DLK1 levels in affected individuals supported the relationship between here described novel DLK1 gene variants with CPP. Nonsense nature of c.357C>G/p.(Tyr119Ter) and an alteration in the evolutionarily conserved nucleotide c.67+78C>T suggested the disruptive nature of the variant's compatibility with CPP.
- 17 February 2024
- Published by Springer Nature in Journal of Endocrinological Investigation
- Vol. 47 (8) , 2041-2052
Open AccessNovel variants ensued genomic imprinting in familial central precocious puberty
Introduction: Central precocious puberty (CPP) is characterized by the early onset of puberty and is associated with the critical processes involved in the pubertal switch. The puberty-related gene pool in the human genome is considerably large though few have been described in CPP. Within those genes, the genomic imprinting features of the MKRN3 and DLK1 genes add additional complexity to the understanding of the pathologic pathways. This study aimed to investigate the molecular etiology in the CPP cohort. Methods: Eighteen familial CPP cases were investigated by Sanger sequencing for five CPP-related genes; DLK1, KISS1, KISS1R, MKRN3, and PROKR2. Segregation analysis was performed in all patients with pathogenic variants. Using an ELISA test, the functional pathogenicity of novel variants was also investigated in conjunction with serum delta-like 1 homolog (DLK1) concentrations. Results: In three probands, a known variant in the MKRN3 gene (c.982C>T/p.(Arg328Cys)) and two novel variants in the DLK1 gene (c.357C>G/p.(Tyr119Ter) and c.67+78C>T) were identified. All three were inherited from the paternal allele. The individuals carrying the DLK1 variants had low detectable DLK1 levels in their serum. Conclusions: The frequencies were 5.5% (1/18) for MKRN3 11% (2/18) for DLK1, and none for either KISS1, KISS1R, and PROKR2. Low serum DLK1 levels in affected individuals supported the relationship between here described novel DLK1 gene variants with CPP. Nonsense nature of c.357C>G/p.(Tyr119Ter) and an alteration in the evolutionarily conserved nucleotide c.67+78C>T suggested the disruptive nature of the variant's compatibility with CPP.
- Open Access
- 31 August 2023
- Published by Cukurova Anestezi ve Cerrahi Bilimler Dergisi in Cukurova Anestezi ve Cerrahi Bilimler Dergisi
- Vol. 6 (2) , 251-257
The importance of alterations in innate lymphoid cell subsets in patients with non-small cell lung cancer and their role in tumorigenesis
Objective. Non-small cell lung cancer (NSCLC) is one of the leading causes of cancer-related morbidity and mortality. Diverse functions of innate lymphoid cells (ILCs) and NK cell subsets are investigated thoroughly in cancer immunotherapy. ILC and recently described NK cell subsets in NSCLC patients’ blood samples and tumor draining lymph nodes were investigated. Methods. The study included chemotherapy and/or radiotherapy-naive NSCLC patients with clinical stage T1-4N0-2M0 who underwent video-assisted mediastinal lymphadenectomy and 14 healthy controls. Mononuclear cells were isolated from peripheral blood of both groups and mediastinal lymph nodes of NSCLC patients. NK cells and ILC subsets were analyzed by flow cytometry. Results. Total NK cells are shown to be increased in peripheral blood of NSCLC patients compared to lymph nodes while the ratio of CD56dimCD16- exhausted NK cells is higher in lymph nodes than in blood samples of NSCLC patients. Compared to control group, peripheral blood ILC1 cells were lower in NSCLC patients, however ILC2 and ILC3 cells were significantly increased. However, mediastinal lymph nodes of NSCLC patients had decreased ratio of ILC2 and increased ratio of ILC3 cells than in peripheral blood of patients. NSCLC patients had significantly increased ratio of NKp44-ILC3 cells and decreased ratio of NKp44+ILC3 in lymph nodes. Conclusion. Decreased ratio of ILC1 cells is an important indicator of impaired anti-tumoral response. Increased in the ratio of NKp44-ILC3 cells in NSCLC patients may potentially contribute to tumor progression. These findings highlight the distinct roles of ILCs, which play a pivotal role in the pathogenesis of lung cancer.
- 31 August 2023
- Published by Cukurova Anestezi ve Cerrahi Bilimler Dergisi in Cukurova Anestezi ve Cerrahi Bilimler Dergisi
- Vol. 6 (2) , 251-257
Open AccessThe importance of alterations in innate lymphoid cell subsets in patients with non-small cell lung cancer and their role in tumorigenesis
Objective. Non-small cell lung cancer (NSCLC) is one of the leading causes of cancer-related morbidity and mortality. Diverse functions of innate lymphoid cells (ILCs) and NK cell subsets are investigated thoroughly in cancer immunotherapy. ILC and recently described NK cell subsets in NSCLC patients’ blood samples and tumor draining lymph nodes were investigated. Methods. The study included chemotherapy and/or radiotherapy-naive NSCLC patients with clinical stage T1-4N0-2M0 who underwent video-assisted mediastinal lymphadenectomy and 14 healthy controls. Mononuclear cells were isolated from peripheral blood of both groups and mediastinal lymph nodes of NSCLC patients. NK cells and ILC subsets were analyzed by flow cytometry. Results. Total NK cells are shown to be increased in peripheral blood of NSCLC patients compared to lymph nodes while the ratio of CD56dimCD16- exhausted NK cells is higher in lymph nodes than in blood samples of NSCLC patients. Compared to control group, peripheral blood ILC1 cells were lower in NSCLC patients, however ILC2 and ILC3 cells were significantly increased. However, mediastinal lymph nodes of NSCLC patients had decreased ratio of ILC2 and increased ratio of ILC3 cells than in peripheral blood of patients. NSCLC patients had significantly increased ratio of NKp44-ILC3 cells and decreased ratio of NKp44+ILC3 in lymph nodes. Conclusion. Decreased ratio of ILC1 cells is an important indicator of impaired anti-tumoral response. Increased in the ratio of NKp44-ILC3 cells in NSCLC patients may potentially contribute to tumor progression. These findings highlight the distinct roles of ILCs, which play a pivotal role in the pathogenesis of lung cancer.
- 28 March 2023
- Published by Marmara University in Clinical and Experimental Health Sciences
- Vol. 13 (1) , 99-104
Intracellular Levels of IL-10 and STAT3 in Patients with Chronic Lymphocytic Leukemia
Objective: Chronic Lymphocytic Leukemia (CLL) is characterized by the accumulation of CD5+CD19+ B cells in the bone marrow and peripheral blood. Recent studies indicated that expression of IL-10, AID and mir-155 which are regulated by STAT3 are increased in CLL patients. CD5+CD19+ regulator B (Breg) cells secrete IL-10 and suppress the immune system. While the CLL cells show similar immunophenotypic properties to Breg cells, they are also thought to be functionally similar. In this study, STAT3 and IL-10 levels of CLL patients were investigated. Methods: Peripheral blood samples obtained from patients (n:24) and healthy controls (n:14). Peripheral blood mononuclear cells were cultured for 48 hours in the presence and absence of CpG for IL-10 expression and cultured with and without PMA for STAT3 expression. IL-10 and STAT3 expression were analyzed with anti-CD5, anti-CD19, anti-CD38, anti-STAT3 and anti-IL-10 monoclonal antibodies by using flow cytometry. Results: Compared to healthy subjects, increased IL-10+, IL-10+CD19+, STAT3+CD19+ were obtained in lymphocyte population of patients. Increased IL-10 was showed CD19+ B cells of CLL patients. Our results showed that IL-10 levels had no significant difference between CD5+CD19+ cells, whereas STAT3 levels were found lower in patient compared to healthy controls. Conclusion: These results made us thought that the levels of IL-10 and STAT3 expression in CLL B cells is clearly different from normal B lymphocytes might have a role in the biology of CLL. It is believed that the presented data will contribute to the studies that scrutinize the similarity of CLL cells to Breg cells.
- 28 March 2023
- Published by Marmara University in Clinical and Experimental Health Sciences
- Vol. 13 (1) , 99-104
Intracellular Levels of IL-10 and STAT3 in Patients with Chronic Lymphocytic Leukemia
Objective: Chronic Lymphocytic Leukemia (CLL) is characterized by the accumulation of CD5+CD19+ B cells in the bone marrow and peripheral blood. Recent studies indicated that expression of IL-10, AID and mir-155 which are regulated by STAT3 are increased in CLL patients. CD5+CD19+ regulator B (Breg) cells secrete IL-10 and suppress the immune system. While the CLL cells show similar immunophenotypic properties to Breg cells, they are also thought to be functionally similar. In this study, STAT3 and IL-10 levels of CLL patients were investigated. Methods: Peripheral blood samples obtained from patients (n:24) and healthy controls (n:14). Peripheral blood mononuclear cells were cultured for 48 hours in the presence and absence of CpG for IL-10 expression and cultured with and without PMA for STAT3 expression. IL-10 and STAT3 expression were analyzed with anti-CD5, anti-CD19, anti-CD38, anti-STAT3 and anti-IL-10 monoclonal antibodies by using flow cytometry. Results: Compared to healthy subjects, increased IL-10+, IL-10+CD19+, STAT3+CD19+ were obtained in lymphocyte population of patients. Increased IL-10 was showed CD19+ B cells of CLL patients. Our results showed that IL-10 levels had no significant difference between CD5+CD19+ cells, whereas STAT3 levels were found lower in patient compared to healthy controls. Conclusion: These results made us thought that the levels of IL-10 and STAT3 expression in CLL B cells is clearly different from normal B lymphocytes might have a role in the biology of CLL. It is believed that the presented data will contribute to the studies that scrutinize the similarity of CLL cells to Breg cells.
- 9 January 2023
- Published by Bilimsel Tip Publishing House in Mikrobiyoloji Bulteni
- Vol. 57 (1) , 83-96
IFN-γR1 (CD119) ve IL-12Rβ1 (CD212) Eksikliğinin Akan Hücre Ölçer ile Analizi
Mendelian susceptibility to mycobacterial diseases (MSMD) is a rare primary immune deficiency (PID). IL-12R beta 1 deficiency is the most frequently observed of more than 16 genetic defects that have been identified for MSMD. Genetic and immunological tests are remarkable in the diagnosis of PID. In this study, it was aimed to determine the expression of IFN-gamma R1 and IL-12R beta 1 in patients with MSMD, their relatives, and healthy individuals and to evaluate the importance of flow cytometry as a fast and reliable method in the diagnosis of MSMD. IFN-gamma R1 and IL-12R beta 1 expression levels were analyzed in 32 volunteers including six patients, six relatives, and 20 healthy individuals. The normal range of IFN-gamma R1 and IL-12R beta 1 levels among healthy individuals were determined. IL-12R beta 1 expression level in lympho- cytes was found to be low in one patient's relative, and less than 1% in three patients and in one pa- tient's relative. It was observed that the IL-12R beta 1 expression levels of the patient with STAT1 deficiency were increased compared to the healthy individuals. No difference was found in the expression levels of IFN-gamma R1 and IL-12R beta 1 in one patient, but IFN-gamma R1 expression was decreased in one patient compared to healthy individuals. Our results show that the determination of IL-12R beta 1 and IFN-gamma R1 deficiencies by flow cytometry can be used as a rapid and reliable method for the diagnosis of MSMD. The use of this method as a screening test will enable early diagnosis especially in patients whose genetic diagnosis has not been confirmed and clinically compatible with MSMD. In addition, it is thought that IL-12R beta 1 and IFN-gamma R1 range data obtained from healthy individuals will be considered as a reference source in routine and research studies to be conducted with MSMD.
- 9 January 2023
- Published by Bilimsel Tip Publishing House in Mikrobiyoloji Bulteni
- Vol. 57 (1) , 83-96
IFN-γR1 (CD119) ve IL-12Rβ1 (CD212) Eksikliğinin Akan Hücre Ölçer ile Analizi
Mendelian susceptibility to mycobacterial diseases (MSMD) is a rare primary immune deficiency (PID). IL-12R beta 1 deficiency is the most frequently observed of more than 16 genetic defects that have been identified for MSMD. Genetic and immunological tests are remarkable in the diagnosis of PID. In this study, it was aimed to determine the expression of IFN-gamma R1 and IL-12R beta 1 in patients with MSMD, their relatives, and healthy individuals and to evaluate the importance of flow cytometry as a fast and reliable method in the diagnosis of MSMD. IFN-gamma R1 and IL-12R beta 1 expression levels were analyzed in 32 volunteers including six patients, six relatives, and 20 healthy individuals. The normal range of IFN-gamma R1 and IL-12R beta 1 levels among healthy individuals were determined. IL-12R beta 1 expression level in lympho- cytes was found to be low in one patient's relative, and less than 1% in three patients and in one pa- tient's relative. It was observed that the IL-12R beta 1 expression levels of the patient with STAT1 deficiency were increased compared to the healthy individuals. No difference was found in the expression levels of IFN-gamma R1 and IL-12R beta 1 in one patient, but IFN-gamma R1 expression was decreased in one patient compared to healthy individuals. Our results show that the determination of IL-12R beta 1 and IFN-gamma R1 deficiencies by flow cytometry can be used as a rapid and reliable method for the diagnosis of MSMD. The use of this method as a screening test will enable early diagnosis especially in patients whose genetic diagnosis has not been confirmed and clinically compatible with MSMD. In addition, it is thought that IL-12R beta 1 and IFN-gamma R1 range data obtained from healthy individuals will be considered as a reference source in routine and research studies to be conducted with MSMD.
- Open Access
- 3 January 2023
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 133 (1)
The Notch1/CD22 signaling axis disrupts Treg function in SARS-CoV-2–associated multisystem inflammatory syndrome in children
Multisystem inflammatory syndrome in children (MIS-C) evolves in some pediatric patients following acute infection with SARS-CoV-2 by hitherto unknown mechanisms. Whereas acute-COVID-19 severity and outcomes were previously correlated with Notch4 expression on Tregs, here, we show that Tregs in MIS-C were destabilized through a Notch1-dependent mechanism. Genetic analysis revealed that patients with MIS-C had enrichment of rare deleterious variants affecting inflammation and autoimmunity pathways, including dominant-negative mutations in the Notch1 regulators NUMB and NUMBL leading to Notch1 upregulation. Notch1 signaling in Tregs induced CD22, leading to their destabilization in a mTORC1-dependent manner and to the promotion of systemic inflammation. These results identify a Notch1/CD22 signaling axis that disrupts Treg function in MIS-C and point to distinct immune checkpoints controlled by individual Treg Notch receptors that shape the inflammatory outcome in SARS-CoV-2 infection.
- 3 January 2023
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 133 (1)
Open AccessThe Notch1/CD22 signaling axis disrupts Treg function in SARS-CoV-2–associated multisystem inflammatory syndrome in children
Multisystem inflammatory syndrome in children (MIS-C) evolves in some pediatric patients following acute infection with SARS-CoV-2 by hitherto unknown mechanisms. Whereas acute-COVID-19 severity and outcomes were previously correlated with Notch4 expression on Tregs, here, we show that Tregs in MIS-C were destabilized through a Notch1-dependent mechanism. Genetic analysis revealed that patients with MIS-C had enrichment of rare deleterious variants affecting inflammation and autoimmunity pathways, including dominant-negative mutations in the Notch1 regulators NUMB and NUMBL leading to Notch1 upregulation. Notch1 signaling in Tregs induced CD22, leading to their destabilization in a mTORC1-dependent manner and to the promotion of systemic inflammation. These results identify a Notch1/CD22 signaling axis that disrupts Treg function in MIS-C and point to distinct immune checkpoints controlled by individual Treg Notch receptors that shape the inflammatory outcome in SARS-CoV-2 infection.